Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial. (2022)
Attributed to:
Expansion of state-of-the-art MR imaging infrastructure for pulmonary disease stratification: POLARIS
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12931-022-01949-3
PubMed Identifier: 35144620
Publication URI: http://europepmc.org/abstract/MED/35144620
Type: Journal Article/Review
Volume: 23
Parent Publication: Respiratory research
Issue: 1
ISSN: 1465-9921